Expressions of EZH2 and NOTCH3 pathway in osteosarcoma and their roles in osteosarcoma stem cells

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Osteosarcoma (OS) is the most common primary bone malignancy, with poorly understood underlying mechanisms.
• Enhancer of zeste homologue 2 (EZH2) and the NOTCH pathway are implicated in carcinogenesis but their specific roles in OS require further elucidation.
• Stem-like phenotypes are observed in OS cells, suggesting a role for stemness in tumor progression.

Purpose of the Study:

• To investigate the expression and correlation of EZH2, Notch3, HES1, and Nanog in osteosarcoma.
• To determine the association of these factors with clinical outcomes, including tumor relapse, metastasis, and survival.
• To explore the functional role of EZH2 and the Notch3 pathway in osteosarcoma stem cell self-renewal.

Main Methods:

• Detection and statistical analysis of EZH2, Notch3, HES1, and Nanog expression in OS samples.
• Verification of stem-like phenotypes in OS cells.
• Investigation of the relationship between gene expression, clinical data, and stem cell properties.

Main Results:

• Higher expression of EZH2, Notch3 pathway activation, or Nanog was significantly associated with tumor relapse, metastasis, and shorter survival.
• The Notch3 pathway was found to be activated in osteosarcoma stem cells.
• EZH2 overexpression promoted Notch3 pathway activation and HES1 expression, leading to increased stem cell-related gene expression and self-renewal in OS cells.

Conclusions:

• EZH2, Notch3, and Nanog are significant prognostic factors in osteosarcoma.
• EZH2 plays a crucial role in maintaining osteosarcoma cell self-renewal, potentially through activation of the Notch3 pathway.
• Targeting EZH2 and the Notch3 pathway may offer therapeutic strategies for osteosarcoma.